N
Neo Medical
Develops transformational value-based healthcare technologies for thoracolumbar functional fusion
About Neo Medical
Neo Medical SA, founded in 2013 by Jonas Larsson and Vincent Lefauconnier, is a Swiss medical technology company focused on advancing spinal surgery. The company's creation was fueled by Lefauconnier's two decades of experience in the spine industry, where he observed significant market growth without a corresponding improvement in patient outcomes. This frustration led to a "blank-slate approach" to redesign spinal surgery solutions. Lefauconnier, with a background in biology and marketing, previously held roles at Medtronic and Stryker and was the Chief Commercial Officer at Vexim, a startup acquired by Stryker. He met Larsson at Stryker, who had been developing the concepts for Neo Medical since 2012.
Operating in the thoracolumbar spine surgery market, which is valued at approximately $7.6 billion, Neo Medical provides its technology to surgeons and healthcare providers in Europe and the United States. The business model centers on selling a comprehensive platform of surgical products and digital tools. The company targets its solutions for a variety of spinal conditions, including degenerative disc disease, spinal stenosis, and traumatic injuries. A key milestone was the acquisition of its German commercial partner, TriOs Medical, in 2021 to strengthen its position in that market. Neo Medical has raised a total of $112 million over six financing rounds, with a significant $68 million Series B in September 2024 led by Gyrus Capital to fuel US expansion.
The company's core offering is the Neo Universal™ platform, an integrated ecosystem combining specialized hardware, procedural techniques, and digital solutions to facilitate more effective spinal fusion surgeries. This platform dramatically simplifies the surgical process, replacing traditional instrument sets of over 400 pieces with just five multi-functional instruments and a streamlined set of universal implants. The hardware includes 3D-printed titanium mesh cages and advanced screw systems. A key digital component is ADVISE™, an AI-driven, augmented reality platform that provides surgeons with real-time intraoperative data on an iPad to support personalized treatments. This integrated approach has been shown to reduce surgical time by up to 29%, cut infection risk by 50%, and lower implant failure rates, which can decrease the need for revision surgeries by as much as 50%. The products are sterile, single-use, and pre-packaged, which improves efficiency and reduces the hospital's environmental footprint.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 95
- Open positions
- 4
- Dealroom signal
- 90.0/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Surgery, Degenerative Diseases, DT and LS, science-based, Swiss DT MedTech
- Technology
- Hardware, Deep Tech
- Business model
- Manufacturing
- Client focus
- B2B
News
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Sep 2024 | $68M | $272M | Vincent Lefauconnier · Jonas Larsson · Gyrus Capital | ↗ |
| CONVERTIBLEOther financing | Feb 2023 | $0 | — | Verve Ventures | — |
Growth signals
Latest recorded traffic for Neo Medical is 3.2K monthly website visits, up 45.5% over the last three months. Neo Medical's team grew 6.7% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Neo Medical in the Bourg-en-Lavaux ecosystem
The Neo Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
Verve Ventures
4FOX Ventures
Gyrus CapitalVincent Lefauconnier
Jonas Larsson
Series B and later2 investors entered at this stage
Orthofix
Swisscom Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Neo Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Neo Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










